Clinical Trial Opportunity for Adults with Ankylosing Spondylitis

By Spondylitis Association of America

Thursday, December 13, 2018

The following is an announcement from SAA about a third party clinical trial. SAA is not affiliated with this study, the researchers, or the drug manufacturer.

 

A Phase 3 clinical trial is now recruiting patients over the age of 18 with active spondylitis (AS) to participate.

The purpose of the trial, titled, “Efficacy and Safety of Tofacitinib in Subjects with Active Ankylosing Spondylitis (AS)” is to determine if Tofacitinib is safe and effective in subjects with active ankylosing spondylitis.

You may qualify to participate in this study if you:

  • • Are 18 years of age or older
  • • Have a clinical of diagnosis of Ankylosing Spondylitis (AS)
  • • Must have a radiograph of SI joints (AP Pelvis) documenting diagnosis of AS.
  • • Have active disease despite nonsteroidal anti-inflammatory drug (NSAID) therapy or intolerant to NSAIDs.

More information can be found on the Clinical Trials website

This study is sponsored by Pfizer Pharmaceuticals. For more information you can call the Pfizer call center at (800)718–1021 or email ClinicalTrials.gov_Inquiries@pfizer.com

To submit contact information to learn of study centers near you,click here

 

Learn more about participating in Clinical Studies

 

Print

Stay Informed

Text/HTML

Careers

Visit our careers page for available positions

Contact Us

Spondylitis Association of America

16360 Roscoe Blvd.  Ste. 100
Van Nuys, CA 91406

Email

info@spondylitis.org

Information Requests

(800) 777-8189 U.S. only
or (818) 892-1616
*Please note: This is not a Crisis Hotline. If you are in a life-threatening crisis, please dial 911 for immediate help in the US. Please follow this link for crisis intervention resources.

Give With Confidence

Independent Charities of America